10.1128/AEM.02787-06 Kim JE, Eom HJ, Kim Y, Ahn JE, Kim JH, Han NS: Enhancing acid tolerance of Leuconostoc mesenteroides with glutathione
A separate Phase 3 trial called ATTAIN-MAINTAIN, also disclosed in the Q4 deck, showed that patients switching from injectable semaglutide or tirzepatide to oral orforglipron maintained their weight loss over 52 weeks of extension
Originally derived from a naturally occurring compound in human gastric juice, BPC-157 (Body Protection Compound-157) has shown impressive potential in tissue repair, inflammation reduction, angiogenesis , and gut protection all without altering hormone levels
Even more striking, 86% of participants on the 12 mg dose achieved normal liver fat levels (below 5%) at 24 weeks
Our medical weight loss coaching program is designed to help you make lifestyle choices and changes that support your weight loss journey to the fullest